These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25249434)

  • 41. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas.
    Ransom DT; Ritland SR; Moertel CA; Dahl RJ; O'Fallon JR; Scheithauer BW; Kimmel DW; Kelly PJ; Olopade OI; Diaz MO
    Genes Chromosomes Cancer; 1992 Nov; 5(4):357-74. PubMed ID: 1283325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Preliminary study on the gene expression profiles of oligodendrogliom as with cDNA array].
    Jiang R; Pu P; Zheng Y; Kang C; Wang G; Wang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Oct; 19(5):379-82. PubMed ID: 12362310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas.
    Kitange G; Misra A; Law M; Passe S; Kollmeyer TM; Maurer M; Ballman K; Feuerstein BG; Jenkins RB
    Genes Chromosomes Cancer; 2005 Jan; 42(1):68-77. PubMed ID: 15472895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of chromosomal changes by interphase cytogenetics in biopsies of recurrent astrocytomas and oligodendrogliomas.
    Rosso SM; van Dekken H; Krishnadath KK; Alers JC; Kros JM
    J Neuropathol Exp Neurol; 1997 Oct; 56(10):1125-31. PubMed ID: 9329456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma.
    Sahm F; Reuss D; Koelsche C; Capper D; Schittenhelm J; Heim S; Jones DT; Pfister SM; Herold-Mende C; Wick W; Mueller W; Hartmann C; Paulus W; von Deimling A
    Acta Neuropathol; 2014 Oct; 128(4):551-9. PubMed ID: 25143301
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low-grade developmental and epilepsy associated brain tumors: a critical update 2020.
    Slegers RJ; Blumcke I
    Acta Neuropathol Commun; 2020 Mar; 8(1):27. PubMed ID: 32151273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mixed glioma with molecular features of composite oligodendroglioma and astrocytoma: a true "oligoastrocytoma"?
    Huse JT; Diamond EL; Wang L; Rosenblum MK
    Acta Neuropathol; 2015 Jan; 129(1):151-3. PubMed ID: 25359109
    [No Abstract]   [Full Text] [Related]  

  • 48. ATRX immunohistochemistry can help refine 'not elsewhere classified' categorisation for grade II/III gliomas.
    Burford C; Laxton R; Sidhu Z; Aizpurua M; King A; Bodi I; Ashkan K; Al-Sarraj S
    Br J Neurosurg; 2019 Oct; 33(5):536-540. PubMed ID: 31018710
    [No Abstract]   [Full Text] [Related]  

  • 49. Gene expression profiling with oligonucleotide microarrays distinguishes World Health Organization grade of oligodendrogliomas.
    Watson MA; Perry A; Budhraja V; Hicks C; Shannon WD; Rich KM
    Cancer Res; 2001 Mar; 61(5):1825-9. PubMed ID: 11280731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pattern of gene expression and possible relation of steroidogenic genes in oligodendroglial tumors.
    Seol HJ; Kim JE; Wang KC; Kim SK; Seo JS; Park SH; Jung HW
    Int J Oncol; 2009 Jan; 34(1):181-90. PubMed ID: 19082489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical importance of c-Met protein expression in high grade astrocytic tumors.
    Hirose Y; Kojima M; Sagoh M; Hayashi T; Murakami H; Shimazaki K; Yoshida K; Kawase T
    Neurol Med Chir (Tokyo); 1998 Dec; 38(12):851-8; discussion 858-9. PubMed ID: 10063359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphologic and molecular genetic aspects of oligodendroglial neoplasms.
    Bigner SH; Rasheed BK; Wiltshire R; McLendon RE
    Neuro Oncol; 1999 Jan; 1(1):52-60. PubMed ID: 11550302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polymorphous oligodendroglioma of Zülch revisited: a genetically heterogeneous group of anaplastic gliomas including tumors of bona fide oligodendroglial differentiation.
    Hewer E; Beck J; Murek M; Kappeler A; Vassella E; Vajtai I
    Neuropathology; 2014 Aug; 34(4):323-32. PubMed ID: 24444336
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology and Molecular Epidemiology.
    Bauchet L; Ostrom QT
    Neurosurg Clin N Am; 2019 Jan; 30(1):1-16. PubMed ID: 30470396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pleomorphic xanthoastrocytoma and oligodendroglioma: collision of 2 morphologically and genetically distinct anaplastic components.
    Hattab EM; Martin SE; Shapiro SA; Cheng L
    J Neurosurg; 2011 Jun; 114(6):1648-53. PubMed ID: 21214337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptional inactivation of TP73 expression in oligodendroglial tumors.
    Dong S; Pang JC; Hu J; Zhou LF; Ng HK
    Int J Cancer; 2002 Mar; 98(3):370-5. PubMed ID: 11920588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes.
    Senger DL; Tudan C; Guiot MC; Mazzoni IE; Molenkamp G; LeBlanc R; Antel J; Olivier A; Snipes GJ; Kaplan DR
    Cancer Res; 2002 Apr; 62(7):2131-40. PubMed ID: 11929835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. OLIG2 as a specific marker of oligodendroglial tumour cells.
    Marie Y; Sanson M; Mokhtari K; Leuraud P; Kujas M; Delattre JY; Poirier J; Zalc B; Hoang-Xuan K
    Lancet; 2001 Jul; 358(9278):298-300. PubMed ID: 11498220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
    Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
    J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microvascular characteristics of lower-grade diffuse gliomas: investigating vessel size imaging for differentiating grades and subtypes.
    Guo H; Kang H; Tong H; Du X; Liu H; Tan Y; Yang Y; Wang S; Zhang W
    Eur Radiol; 2019 Apr; 29(4):1893-1902. PubMed ID: 30276676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.